InvaGen Pharmaceuticals has recalled 1,776 bottles of Testosterone Topical Solution (30mg per pump) due to a defect in the container's actuator pump. This mechanical failure can cause the pump to function improperly, preventing the delivery of the correct prescribed dose of medication. The affected products were manufactured by Cipla Ltd and distributed nationwide in 110 mL bottles designed to deliver 90 mL of solution. If you use this medication, check your bottle for lot numbers GH80480 or GH80481 with an expiration date of March 2020.
A malfunctioning actuator pump may deliver an inconsistent or incorrect amount of testosterone to the patient. This could lead to under-dosing or over-dosing, which may negatively impact the effectiveness of the treatment or cause unintended side effects related to hormone levels.
Drug recall return and refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.